Reduction of hypokalaemia with finerenone: a drug or class-specific effect?

Eur Heart J Cardiovasc Pharmacother. 2025 Jan 8:pvae089. doi: 10.1093/ehjcvp/pvae089. Online ahead of print.

Giuseppe M C Rosano^{1

2}, Koh Ono³, Egidio Imbalzano⁴, Koji Hasegawa⁵

¹ Department of Human Sciences and Promotion of Quality of Life, Chair of Pharmacology, San Raffaele University of Rome, via di val cannuta, Rome 00163, Italy.
² Cardiology, San Raffaele Cassino Hospital, Via Gaetano di Biasio, 1, Cassino FR 03043, Italy.
³ Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan.
⁴ Department of Internal Medicine, University of Messina, Via Consolare Valeria Cap, Messina 98125, Italy.
⁵ National Hospital Organization Kyoto Medical Centre, 1-1 Mukaihaya-cho, Fukakusa, Fushimi-ku, Kyoto 612-8555, Japan.

No abstract available

Publication types